Skip to main content

Table 1 Baseline demographics, clinical chemistry and interval between symptom onset and baseline presentation.

From: Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial

Variable POCT
(n = 218)
Controls (n = 151)
  n (%)
or mean ± SD
n (%)
or mean ± SD
Men 121 (57.9) 83 (58.0)
Age [years] 65 ± 16 64 ± 17
Weight [kg] 80 ± 17 78 ± 17
Height 169 ± 10 169 ± 9
Body mass index [kg/m2] 28 ± 5 27 ± 6
Glucose [mmol/l] 5.9 ± 1.5 6.3 ± 2.1
Creatinine [mmol/l] 84.4 ± 29.1 84.4 ± 22.4
High-density lipoprotein [mmol/l] 1.4 ± 0.7 1.4 ± 0.5
Low-density lipoprotein [mmol/l] 2.9 ± 1.0 3.3 ± 1.0
Triglycerides [mmol/l] 1.7 ± 1.1 1.7 ± 1.0
Interval between symptom onset and baseline visit [all patients, days] 3.3 ± 9.8 1.7 ± 1.7
Interval between symptom onset and baseline visit [patients presenting <5 days after symptom onset, days] 1.2 ± 1.4
(n = 185)
1.5 ± 1.4
(n = 141)
  1. POCT, point-of-care testing; SD, standard deviation.